Nkarta (NKTX) Treasury Shares (2019 - 2026)
Nkarta (NKTX) posted quarterly Treasury Shares of $1.0 million for Q1 2026, up 17.71% year-over-year from $854884.0 in Q1 2025, and up 55.06% quarter-over-quarter from $648959.0 in Q4 2025.
Nkarta (NKTX) Treasury Shares (2019 - 2026) Analysis & Trends
Nkarta's Treasury Shares history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 17.71% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 17.71% YoY), while the FY2025 annual figure was $648959.0, down 44.43% from the prior year.
- Treasury Shares for Q1 2026 stood at $1.0 million, up from $648959.0 in the prior quarter.
- The five-year high for Treasury Shares was $1.2 million in Q1 2024, with the low at $229418.0 in Q1 2022.
- The 5-year median for Treasury Shares is $716956.0 (2023), against an average of $755077.1.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares surged 2104.61% in 2022, then plunged 44.43% in 2025.
- Nkarta's Treasury Shares stood at $356728.0 in 2022, then jumped by 66.73% to $594768.0 in 2023, then surged by 96.36% to $1.2 million in 2024, then slumped by 44.43% to $648959.0 in 2025, then surged by 55.06% to $1.0 million in 2026.
- Business Quant data shows NKTX's Treasury Shares at $1.0 million in Q1 2026, $648959.0 in Q4 2025, and $661636.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 951,360.00 |
| Jun 30, 2026 | 951,360.00 |
| Mar 31, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 648,959.00 |
| Dec 31, 2025 | 648,959.00 |
| Sep 30, 2025 | 661,636.00 |
| Sep 30, 2025 | 661,636.00 |
| Jun 30, 2025 | 832,299.00 |
| Jun 30, 2025 | 832,299.00 |
| Mar 31, 2025 | 854,884.00 |
| Mar 31, 2025 | 854,884.00 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.22 Mn |